Cargando…
Complement control for COVID-19
Excessive complement activation contributes to lung disease and adverse patient outcomes in COVID-19 (see the related research articles by Yan et al. and Ma et al.).
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for the Advancement of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432947/ https://www.ncbi.nlm.nih.gov/pubmed/34035117 http://dx.doi.org/10.1126/sciimmunol.abj1014 |